entertainment -WSS

entertainment

author：entertainment 2025-09-29 07:35:14 - browse：55

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： The science behind Janet Jackson's pregnancy at 49

explore

WSS

Why drug prescriptions should include diagnoses

Paxlovid study fails to answer questions over benefit for broader groups

Free speech concerns arise in wake of journal editor Eisen's firing

Why we need to separate burnout from moral injury in health care

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

In areas with more Black doctors, Black people live longer

explore

entertainment

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ask STAT: What do you want to know about ChatGPT in medicine?

Virginia high school admissions case could be legal follow

Ambulance rides for just $100? Advisers want major billing fixes

Guidelines to prevent youth baseball injuries need more muscle

The Sacklers, horror, and ‘The Fall of the House of Usher’

Bright Health sells Medicare Advantage business to Molina

FDA approves potent Eli Lilly obesity drug, Zepbound

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medicare will require more price transparency from hospitals

Wikipedia

MoonLake credibility takes another hit with mid

STAT's guide to the next generation of CAR

In areas with more Black doctors, Black people live longer

New guidelines on severe brain injury complicate already difficult decisions

Free speech concerns arise in wake of journal editor Eisen's firing

Will General Catalyst be the first of many hospital takeovers?

explore

explore

hotspot

hotspot